logo
Select company
Select metric
$ 2.51MNon-Current Debt
VS
Market
73
Sector
63
Industry
53
History
-
$ 11.25Close
$ 8.84 - $ 12.53 52-Week Range
Ticker Information

Ticker

BBOT

Company Name

BRIDGEBIO ONCOLOGY THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

BRIDGEBIO ONCOLOGY THERAPEUTICS INC - Non-Current Debt Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

BBOT - DebtNC Historical data
DateNon-Current Debt
6/30/2025$ 2.51M
3/31/2025$ 0
12/31/2024$ 0
9/30/2024$ 0
6/30/2024$ 0
3/31/2024$ 0
12/31/2023$ 0
9/30/2023$ 0
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • BRIDGEBIO ONCOLOGY THERAPEUTICS INC's latest trailing twelve months (TTM) DebtNC stands at $ 0.
  • Over the past 5 years, BRIDGEBIO ONCOLOGY THERAPEUTICS INC's average DebtNC has been $ 314.25K.
  • The median DebtNC for BRIDGEBIO ONCOLOGY THERAPEUTICS INC during this period was $ 0
  • BRIDGEBIO ONCOLOGY THERAPEUTICS INC reached its highest DebtNC over the past 5 years at $ 2.51M.
  • The lowest DebtNC recorded by BRIDGEBIO ONCOLOGY THERAPEUTICS INC in the same timeframe $ 0

Definition of Non-Current Debt

[Balance Sheet] The non-current (long-term) portion of [Debt] includes the formal borrowings that are due after the period of one year; reported if the company operates a classified balance sheet that segments current and non-current [Liabilities]

BBOT - Non-Current Debt, Last 5 years

$ 0

Minimum

Sep 30, 2023

$ 2.51M

Maximum

Jun 30, 2025

$ 314.25K

Average

$ 0

Median

DebtNC Benchmark Analysis

The chart above depicts the distribution of DebtNC for companies in the Total Stock Market. The average DebtNC of the companies is $ 67.17M with a standard deviation of $ 114.68M.
The following table provides additional summary stats:
DebtNC in the Market:
filtered constituents2.41K
min$ 0
max$ 477.83M
average$ 67.17M
median$ 7.83M
std$ 114.68M